NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹466 Cr | ₹428 Cr | ₹439 Cr | ₹363 Cr | ₹369 Cr |
What is the latest Total Current Liabilities ratio of NEULAND LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹466 Cr |
Mar2024 | ₹428 Cr |
Mar2023 | ₹439 Cr |
Mar2022 | ₹363 Cr |
Mar2021 | ₹369 Cr |
How is Total Current Liabilities of NEULAND LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹466 Cr | 8.89 | |
Mar2024 | ₹428 Cr | -2.57 | |
Mar2023 | ₹439 Cr | 20.87 | |
Mar2022 | ₹363 Cr | -1.45 | |
Mar2021 | ₹369 Cr | - |
Compare Total Current Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹15,751.7 Cr | 4.4% | -7.8% | 52.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 4.4% |
-7.8% |
52.1% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses